Study on the relation between renal tubular disorders and. gomerular dysfunction in the early phase of insulin-dependent diabetes

Size: px
Start display at page:

Download "Study on the relation between renal tubular disorders and. gomerular dysfunction in the early phase of insulin-dependent diabetes"

Transcription

1 57 Study on the relation between renal tubular disorders and gomerular dysfunction in the early phase of insulin-dependent diabetes mellitus in children TADASHI ASAMI, TOKUSHI NAKANO, KAORU SAKAI Department of Pediatrics, School of Medicine, Niigata University Key words: insulin dependent diabetes mellitus, diabetic nephropathy, microalbuminuria, NAG, Ĉ 2-microglobulin Abstract To study the relations between renal tubular disorder and glomerular dysfunction in the early phase of insulin-dependent diabetes mellitus (IDDM), we performed concomitant measurements of urinary Ĉ- D-N-acetyl glucosaminidase (NAG), Ĉ2-microglobulin (BMG), and microalbumin in 29 of pediatric patients with IDDM, 15 normal controls, and 83 patients with non-diabetic ketoacidosis. Urinary NAG levels were significantly elevated in the IDDM patients compared with controls. Urinary BMG levels were also elevated in IDDM, however, they were not as prominent as NAG levels. Although urinary microalbumin levels were elevated in the IDDM patients, statistical analysis did not show any significant difference between the IDDM patients and controls. Urinary NAG and BMG concentrations were also increased in patients with non-diabetic ketoacidosis, suggesting a toxic effect of ketone bodies to renal tubular cells. Statistically significant correlations were noted both between urinary NAG and microalbumin and between urinary BMG and microalbumin. These results suggest that, in early phase of IDDM, microalbuminuria is preceded by elevations in urinary NAG and BMG levels, and that keton bodies have deleterious effects on renal tubular cells. Introduction Glomerular lesion has been a major concern of diabetic nephropathy since the description of nodular glomerulosclerosis by Kimmelstiel and Wilson [1], which has been supported by recent reports on the presence of microalbuminuria in the earlier phase of diabetes mellitus [2, 3,4,5]. While these reports stress the importance of early glomerular lesion development, a distinctive glycogenic vacuolization of renal tubular cells in diabetic patients has long been recognized as a lesion pathognomonic of diabetes [6]. There have also been several studies on renal tubular involve ment in insulin-dependent diabetes mellitus (IDDM) [7,8,9,10]. Milteny et al. [9] reported that the urinary excretion of Ĉ2-microglobulin Received October 2, 1991 (BMG) and that of certain enzymes including Ĉ-d-n-acetylglucosaminidase (NAG) were signi ficantly increased during ketoacidosis in patients with IDDM and that tubular reabsorption of electrolytes was reduced in poorly controlled diabetics. In addition, a recent report that some disorders might develop in both renal tubule and glomerulus after a short duration of IDDM [10] raises the possibility of a more important role for tubular disorder, than hitherto considered, in the development of diabetic nephropathy. However, since there have been few studies in which concomitant measurements of renal tubular proteins and albumin were carried out in the urine samples from patients both with IDDM and with non-diabetic ketoacidosis, two points remain uncertain: 1) Does ketoacidosis itself affect renal tubular function; and 2) Which is an earlier sign of renal involvement, tubular proteins or albumin, Japanese Journal of Nephrology Vol. 34, No. 1,

2 58 Tadashi Asami, et al. especially in younger IDDM patients? We studied both tubular and glomerular proteins in children with IDDM without overt nephropathy. Subjects and Methods Twenty nine patients with IDDM (12 males and 17 females), with a mean age of 11 years and 5 months (range, 2 to 24), were included in this study. The duration of the disease was between 1 and 11 years (3.8 }3.1 years, mean }SD). At the time of examination, all of the IDDM patients had glucosuria (1,840 }2,950mg/dl in the first-voided morning urine samples) and a mean increased HbAlc level (9.8 }2.7%). Serum creatinine levels were normal (0.43 }0.10mg/dl, mean }1SD n= 29) ranging from 0.30 to 0.60mg/dl, and blood urea nitrogen were also normal (15.2 }4.5mg/dl) ranging from 7 to 23mg/dl. Other urinary findings including protein, red blood cells, and ketone bodies were negative in all of the subjects upon examination. To examine the effect of postural change on the excretion of urinary NAG, BMG, and albumin, two urine samples were obtained on the same day: FVM-urine; the urine voided first in the morning, and OPC-urine; the urine voided at the out-patient clinic of our hospital. To evaluate the effect of ketone bodies on renal tubules, urine samples from 83 patients with non-diabetic ketoacidosis (auto intoxication or cyclic vomiting) also examined for NAG and BMG. Ketoacidosis was diagnosed when urinary ketone body levels were higher than 0.4 nmol/l as described below. Fifteen healthy school children were used as controls with informed consent obtained from one or both parents. Urine samples were kept frozen at ph 4.8 for NAG and at ph 7.5 for BMG until assay, respectively. NAG levels were measured in simul taneously taken urine and serum samples from 14 randomly selected IDDM patients to examine whether urinary NAG levels reflect circulating levels of NAG. NAG values were measured by our method [11]. In brief, 0.lml of urine sample, kept frozen in 1.0ml of 0.1M-phosphate buffer solution at 4.8, was added 1.0ml of substrate solution (4-methylumbelliferyl-N-acetyl-ƒÀ-Dglucosaminide), and incubated at 37 Ž for 60min. The reaction was stopped by addition of 3.0ml of 0.17M-glycine carbonate buffer. The fluores, cence of the reaction mixtures was read at 450nm (excitation wave at 365nm) against a standard solution. BMG was measured by enzymeimmuno assay (Phadezyme EIA Kit, Shionogi) and albumin by radioimmunoassay (Albumin RIA Kit, Phar macia). Urinary creatinine concentrations were determined by an autoanalyzer system of our hospital. The concentrations of urinary ketone bodies were measured using a commercially available kit (Keton-Test, Sanwa) and levels above 0.4nmol/l of urine were defined as ketone-uria [12]. Statistical analysis was performed by Student's t-test combined with the Cochran-Cox correction method. Results Urinary NAG levels (Figure 1, 2) The levels of urinary NAG in the patients were significantly elevated both in FVM- and OPC-urine as compared with those in the controls (Figure 1). The values for FVM-urine and those for OPCurine were not statistically different. Elevations of urinary NAG levels above the normal range (60u/ml) were noted in 7 of 29 (24.1%) IDDM patients, while this was not observed in any of the controls. Urinary NAG levels were lower than 60 u/ml (normal upper limit), ranging between 8.4 and 54.6u/ml, in 18 of 18 (100%) IDDM patients who had no glucosuria at the time of determina tion. In 26 of 29 (89.7%) IDDM patients, the NAG/creatinine (u/mgcr.) ratios in FVM-urine increased to levels + 2SD above the values of the controls, and 15 of 29 (51.7%) for OPC-urine. There was no significant correlation between the NAG values in urine and those in serum (r=0.03), and between the duration of the disease and the urinary NAG level. In 22 of 83 (26.5%) patients with non-diabetic ketoacidosis, the urinary NAG levels also increased above the normal range (Figure 2). Urinary BMG levels (Figure 2, 3) Urinary BMG levels were elevated in the IDDM patients as compared with those in the controls, however, statistical analysis revealed a significant p value only for BMG/gCr. in FVM-urine (Figure 3). High urinary BMG levels above the normal range (200ƒÊg/ml) were found in 6 of 29 (20.7%) IDDM patients. No significant differences were 58 Japanese Journal of Nephrology Vol. 34, No. 1, 1992

3 Renal tubular and glomerular dysfunction in IDDM 59 Fig. 1. Urinary NAG levels in patients with IDDM. The values are expressed in units/ml of urine and units/mg of urinary creatinine. Shaded column represents the mean value in patients with IDDM (insulin-dependent diabetes mellitus), and open column that of normal controls. Urinary NAC levels in IDDM were significantly elevated both in the urine firstly voided in the morning (FVM-urine) and in the urine voided at our outpatient clinic after walking (OPC-urine) compared with those in controls. No significant differences were found between the values in the FVM-urine and in the OPC-urine. noted between the values for FVM-and OPCurines. In non-diabetic ketoacidosis, 26 of 83 (31.3%) patients also showed elevated urinary BMG levels above the normal range (Figure 2). Urinary albumin levels (Figure 4) Although elevations of urinary albumin levels both in ƒàg/ml and ƒàg/gcr, were noted in the IDDM patients compared with controls, statistical Fig. 2. Urinary NAG and ƒà2-microglobulin levels in patients with non-diabetic ketoacidosis. Urinary NAG levels were abnormally high in 22 of 83 (26.5%) patients with non-diabetic ketoacidosis. Urinary ƒà2-microglobulin levels were also increased to above the normal range. Shaded zone represents the normal range of the values. analysis revealed no significant difference. However, 5 of 29 (17.2%) IDDM patients were found to have higher urinary albumin concentra tions beyond 30ƒÀg/ml which Mogesen et al. [4] suggested as the level indicative of later clinical proteinuria development. These five patients had a mean duration of the disease of 6.0 }4.1 years and a mean HbAlc level of 9.5 }2.0%, neither of which were statistically different from those of the remaining IDDM patients with urinary albumin concentrations lower than 30ƒÀg/ml. Japanese Journal of Nephrology Vol. 34, No. 1,

4 60 Tadashi Asami, et al. Fig, 3. Urinary Ĉ2-microglobulin levels in patients with IDDM. The values were expressed in Ĉg/l of urine and Ĉg/gram of urinary creatinine. Ĉ 2-microglobulin levels in IDDM were elevated compared with those in controls. However, statistical analysis revealed a significant p value only in the FVM-urine. No significant differences were noted between the values in the FVM-urine and in the OPC-urine. For the abbreviations used, see the legend in Figure 1. Fig. 4. Urinary microalbumin levels in patients with IDDM. The values are expressed in Ĉg/ml of urine and Ĉg/mg of urinary creatinine. Urinary microalbumin levels in IDDM were elevated compared with those in controls. However, the differences were statistically not significant. 60 Japanese Journal of Nephrology Vol. 34, No. 1, 1992

5 Renal tubular and glomerular dysfunction in IDDM 61 Fig. 5. Correlation between urinary NAG and microalbumin in patients with IDDM. A significant correlation was noted between the levels of urinary NAG and microalbumin both in the FVM-urine and in the OPC-urine. For the abbreviations, see the legend in Figure 1. Relationship among urinary NAG, BMG, and albumin levels Urinary NAG and albumin levels showed a significant correlation both in the FVM-urine (r=0.734, p ƒ0.001) and in the OPC-urine (r=0.496, p ƒ0.01) (Figure 5). A weak but signifi cant correlation was noted between BMG/gCr. and albumin/gcr. (r=0.426, p ƒ0.05). Although other relations were analyzed, the p values were not statistically significant: albumin and BMG; not significant (r=0.083 in FVM-urine and r= in OPC-urine), NAG and BMG; not significant Discussion (r=0.06 in FVM-urine and r=0.238 in OPCurine). In this study we observed a significant eleva tion of urinary NAG both in FVM-and OPCurine, although urinary albumin levels did not show any difference compared with the controls. An increase in urinary BMG was also observed, however, it was not as prominent as NAG. These data partially conflict with those presented by Mogensen [5], who showed that BMG excretion did not increase until urinary albumin exceed 1,000 micrograms per minute. A possible explanation for this may be the difference in age of the subjects at examination, because predictive studies of diabetic nephropathy, based on early microalbuminuria [3,4,13], have been conducted mainly on adult patients in contrast to ours. Since urinary NAG and BMG are known to increase in various renal tubular disorders, and there was no significant correlation between urine and serum NAG values, the elevation NAG is considered of urinary to be caused by the increased excretion of enzymes from lysosomes in tubular cells activated by excessive loading at glucose beyond the reabsorption capacity. Both increased urinary NAG and BMG levels were demonstrated in IDDM patients with glucosuria, but were not found in patients with normal urine. In addition, ketone bodies, examined in patients with non diabetic ketoacidosis, were demonstrated to cause elevations of both urinary NAG and BMG levels. Although the precise mechanism is unknown, these findings suggest that some IDDM patients may have tubular cells more vulnerable to the excessive loading of urinary glucose or ketone bodies than those who do not develp renal complications. Of interest is the statistically significant correla Japanese Journal of Nephrology Vol. 34, No. 1,

6 62 Tadashi Asami, et al. tion between urinary NAG and albumin noted in both FVM-and OPC-urine, and between BMG and albumin noted in both FVM-and OPC-urine, suggesting that albumin excretion rates track quite closely with markers of tubular handling of such as NAG and BMG. In an attempt to find addi tional factors contributing to renal tubular disorders, other clinical and laboratory data were examined. However, the duration of the disease, HbAlc levels, and urinary glucose concentrations were not statistically related to urinary NAG or BMG excretion, and none of the five IDDM patients, having mild micro-albuminuria, showed any difference compared to those without microalbuminuria. Viewing several reports, the presumed relation between the good control and the prevention of diabetic nephropathy remains controversial, and the cumulative incidence of diabetic nephropathy has been reported in only about 35 percent of all IDDM patients [14,15]. These reports suggest that multiple factors, such as blood hyperviscosity [16, 17], hypertension [13,17], glomerular hyperfiltra tion [18], blood rheology changes [16], or even inherited predisposition to hypertension [19,20], may be involved in the development of diabetic nephropathy. In conclusion, we propose that microalbu minuria, predictive of later development of overt diabetic nephropathy, may be preceded by eleva tions in urinary NAG and BMG levels in children with IDDM. Since only limited data are now available, a long-term follow-up study of the 29 IDDM patients is needed to understand the significance in diabetic nephropathy. Mailing address: Tadashi Asami MD Department of Pediatrics, School of Medicine, Niigata University, Asahimachi-dori 757, Niigata, Japan. References 1. Kimmelstiel P, Wilson C: Intercapillary lesions in glomeruli of the kidney. Am J Pathol 12:83-97, Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100: , Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud Y, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. New Engl J Med 311:89-93, Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: , Ritchie S, Waugh D: The pathology of Armanni Ebstein diabetic nephropathy. Am J Pathol 33: , Whiting PH, Ross IS, Borthwick L: Serum and urine N-acetyl-ƒÀ-D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin dependent diabetics. Clin Chim Acta 92: , Ellis EN, Brouhard BH, Lagrone L, Travis LB: Urinary excretion of N-acetyl-ƒÀ-D-glucosaminidase in children with type I diabetes mellitus. Diabetes Care 6: , Milteny M, Korner A, Tulassay T, Szabo A: Tubular dysfunction in type I diabetes mellitus. Arch Dis Child 60: , Watanabe Y, Kunoi K, Maki Y, Nakamura Y, Fusishima M: Contribution of glycemic control to the levels of urinary N-acetyl-ƒÀ-D-glucosaminidase (NAG), total protein, ƒà2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria. Clin Nephrol 28: , Asami T, Watanabe S, Sakai K: Urinary ƒà-d-nacetylglucosaminidase (NAG) and urinary low molecular proteins in renal tubular disorders: Differentiation of renal tubular injury and dysfunction. Acta Medica et Biologica 30: , Harano Y, Shigeta Y: Sensitive and simplified method for the differential determination of keton bodies. Clin Chim Acta 134: , Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T: Incipient nephropathy in Type I (insulin dependent) diabetes. Diabetologia 26: , Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Decker T: Diabetic nephropathy in Type I (insulin dependent) diabetes:an epidemiological study. Diabetologia 25: , Krolewski AS, Quarran JH, Cristlieb AR, bunsick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78: , Solerte SB, Fioravanti M: Hemodynamic alteration in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes. Clin Nephrol 28: , Parving HH, Smidt UM, Frisberg B, Bonnevie Nielsen B, Andersen AR: A prospective study of glomerula filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: , Rosenstock CE, Raskin P: Early diabetic nephropathy assessment and potential interventions. Diab Care 9: , Vivberti GC, Keen H, Wiseman MJ: Raised arterial 62 Japanese Journal of Nephrology Vol. 34, No. 1, 1992

7 Renal tubular and glomerular dysfunction in IDDM 63 pressure in parents of proteinuric insulin dependent diabetics. Br Med J 295: , Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler W, Rand LI: Predisposition to hypertension and susceptibility to renal diseases in insulin-dependent diabetes mellitus. N Eng JMed 318: , 1987 Japanese Journal of Nephrology Vol. 34, No. 1,

Tubular dysfunction and microalbuminuria in insulin dependent diabetes

Tubular dysfunction and microalbuminuria in insulin dependent diabetes Archives of Disease in Childhood, 1988, 63, 244-249 Tubular dysfunction and microalbuminuria in insulin dependent diabetes C WALTON,* H J BODANSKY,* J K WALES,* M A FORBES,t AND E H COOPERt *University

More information

Diabetologia 9. Impact of metabolic control in progression of clinical diabetic nephropathy

Diabetologia 9. Impact of metabolic control in progression of clinical diabetic nephropathy Diabetologia (1987) 3:82-86 Diabetologia 9 Impact of metabolic control in progression of clinical diabetic nephropathy G. Nyberg a, G. Blohm6 z and G. Nord6n 1 Departments of 1Nephrology and 2Medieine

More information

Diabetologia 9 Springer-Verlag 1984

Diabetologia 9 Springer-Verlag 1984 Diabetologia (184) 26:406-410 Diabetologia Springer-Verlag 184 ncipient nephropathy in Type 1 (insulin-dependent) diabetes E. R. Mathiesen, B. Oxenboll, K. Johansen, P. Aa. Svendsen and T. Deckert Steno

More information

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention And Treatment of Diabetic Nephropathy MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention Tight glucose control reduces the development of diabetic nephropathy Progression

More information

Diabetoiogia 9 Springer-Verlag 1985

Diabetoiogia 9 Springer-Verlag 1985 Diabetologia (195) 2: 6-11 Diabetoiogia 9 Springer-Verlag 195 Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes Ch. Hasslacher, W. Stech, P. Wahl

More information

Diabetic Nephropathy in Spontaneously Diabetic Torii (SDT) Rats

Diabetic Nephropathy in Spontaneously Diabetic Torii (SDT) Rats The Open Diabetes Journal, 2011, 4, 45-49 45 Diabetic Nephropathy in Spontaneously Diabetic Torii (SDT) Rats Takeshi Ohta * and Tomohiko Sasase Open Access Biological/Pharmacological Research Laboratories,

More information

Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients

Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients Diabetes Care Publish Ahead of Print, published online May 12, 2009 Albuminuria and GFR Decline in Diabetes Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in

More information

Diabetologia 9 Springer-Verlag 1995

Diabetologia 9 Springer-Verlag 1995 Diabetologia (1995) 38:1218-1222 Diabetologia 9 Springer-Verlag 1995 Albumin excretion rate levels in non-diabetic offspring of NIDDM patients and out nephropathy G. Gruden, P. Cavallo-Perin, C. Olivetti,.

More information

Natural History of Nephropathy in Type I Diabetes. Relationship to Metabolic Control and Blood Pressure

Natural History of Nephropathy in Type I Diabetes. Relationship to Metabolic Control and Blood Pressure Natural History of Nephropathy in Type I Diabetes Relationship to Metabolic Control and Blood Pressure CHRISTOPH HASSLACHER, EBERHARD RITZ, JANKE TERPSTRA, GEBHARD GALLASCH, GABRIELE KUNOWSKI, AND CORNELIA

More information

Diabetologia 9 Springer-Verlag 1994

Diabetologia 9 Springer-Verlag 1994 Diabetologia (1994) 37:708-712 Diabetologia 9 Springer-Verlag 1994 Monitoring kidney function in diabetic nephropathy P. Rossing, A.-S. Astrup, U. M. Smidt, H.-H. Parving Steno Diabetes Center, Gentofte,

More information

Springer-Verlag 1981

Springer-Verlag 1981 Diabetologia (1981) 21:178-183 Diabetologia @ Springer-Verlag 1981 Diabetic Nephropathy: Fault or Destiny? T. Deckert and J. E. Poulsen Steno Memorial Hospital, Gentofte, Denmark Summary. Twenty-one young

More information

Early detection of patients at risk of developing diabetic nephropathy.

Early detection of patients at risk of developing diabetic nephropathy. Early detection patients at risk developing diabetic nephropathy. A longitudinal study urinary albumin excretion H.-H. Parving, B. Oxenb\l=o/\ll,P. Aa. vendsen, J. andahl Christiansen and A. R. Andersen

More information

Diabetologia Springer-Verlag 1986

Diabetologia Springer-Verlag 1986 Diabetologia (1986) 29: 211-215 Diabetologia Springer-Verlag 1986 Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type 1 (insulin-dependent) diabetic patients with incipient

More information

Prediction of microalbuminuria by using spot urine samples and regression analysis to convert spot microalbumin values to 24 hours microalbuminuria

Prediction of microalbuminuria by using spot urine samples and regression analysis to convert spot microalbumin values to 24 hours microalbuminuria International Research Journal of Biochemistry and Bioinformatics Vol. 1(3) pp.071-075, April, 2011 Available online http://www.interesjournals.org/irjbb Copyright 2011 International Research Journals

More information

ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TYPE I DIABETIC NEPHROPATHY DR.NASIM MUSA

ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TYPE I DIABETIC NEPHROPATHY DR.NASIM MUSA ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TYPE I DIABETIC NEPHROPATHY DR.NASIM MUSA Type I IDDM is characterized by The abrupt onset of symptoms Insulinopenia

More information

Coronary Artery Disease Is the Major Determinant of Excess Mortality in Patients With Insulin-Dependent Diabetes Mellitus and Persistent Proteinuria

Coronary Artery Disease Is the Major Determinant of Excess Mortality in Patients With Insulin-Dependent Diabetes Mellitus and Persistent Proteinuria Coronary Artery Disease Is the Major Determinant of Excess Mortality in Patients With Insulin-Dependent Diabetes Mellitus and Persistent Proteinuria James H. Warram,1 Lori MB. Laffel, Om P. Ganda, and

More information

Cardiovascular disease (CVD) is the major cause. Microalbuminuria: Definition, Detection, and Clinical Significance. R e v i e w P a p e r

Cardiovascular disease (CVD) is the major cause. Microalbuminuria: Definition, Detection, and Clinical Significance. R e v i e w P a p e r R e v i e w P a p e r Microalbuminuria: Definition, Detection, and Clinical Significance Robert D. Toto, MD Proteinuria is a sign of abnormal excretion of protein by the kidney but is a nonspecific term

More information

Indian Journal of Nephrology Indian J Nephrol 2001;11: 6-11

Indian Journal of Nephrology Indian J Nephrol 2001;11: 6-11 6 Indian Journal of Nephrology Indian J Nephrol 2001;11: 6-11 ARTICLE Prevalence of microalbuminuria in essential hypertension: A study of patients with mild to moderate hypertension. S Jalal *, FA Sofi

More information

Urine albumin to creatinine ratio-response to exercise in diabetes

Urine albumin to creatinine ratio-response to exercise in diabetes Archives of Disease in Childhood, 1985, 60, 305-310 Urine albumin to creatinine ratio-response to in diabetes I G JEFFERSON, S A GREENE, M A SMITH, R F SMITH, N K G GRIFFIN, AND J D BAUM Children's Diabetes

More information

END-STAGE RENAL DISEASE (ESRD)

END-STAGE RENAL DISEASE (ESRD) /ORIGINAL CONTRIBUTION Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus Holly J. Kramer, MD, MPH Quan Dong Nguyen, MD, MSc Gary Curhan, MD, ScD

More information

Magnitude of end-stage renal disease in IDDM: A 35 year

Magnitude of end-stage renal disease in IDDM: A 35 year Kidney International, Vol. 5 (1996), pp. 241 246 Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study MARTIN KROLEWSKI, PAUL W. EGGERS, and JAMES H. WARRAM Section on Epidemiology &

More information

Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study

Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Indian J Med Res 136, July 2012, pp 46-53 Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Vijay Viswanathan, Priyanka Tilak

More information

Hong Kong J Nephrol 1999;1(1): MKY WONG, et al (IA) measurement of 24-hour urine sample which is known to be liable to inaccurate collection (14

Hong Kong J Nephrol 1999;1(1): MKY WONG, et al (IA) measurement of 24-hour urine sample which is known to be liable to inaccurate collection (14 Detection Hong Kong of Journal microalbuminuria of Nephrology in NIDDM patients 1999;1(1):18-22. ORIGINAL A R T I C L E Detection of microalbuminuria in non-insulin dependent diabetes mellitus (NIDDM)

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level

More information

Reversal of Microalbuminuria A Causative Factor of Diabetic Nephropathy is Achieved with ACE Inhibitors than Strict Glycemic Control

Reversal of Microalbuminuria A Causative Factor of Diabetic Nephropathy is Achieved with ACE Inhibitors than Strict Glycemic Control ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2013; 4(5): 923-928 ORIGINAL RESEARCH ARTICLE Reversal of Microalbuminuria A Causative Factor

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests

More information

Nephrology Dialysis Transplantation

Nephrology Dialysis Transplantation Nephrol Dial Transplant (1998) 13: 3079 3083 Original Article Nephrology Dialysis Transplantation Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus Agneta

More information

Predisposition to hypertension: Risk factor for nephropathy and hypertension

Predisposition to hypertension: Risk factor for nephropathy and hypertension Kidney International, Vol. 41(1992), pp. 723 73 Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM JOSHUA BARZILAY, JAMES H. WARRAM, MARIANNA BAK, LRI M.B. LAFFEL, MITZY

More information

Diabetologia 9 Springer-Verlag 1981

Diabetologia 9 Springer-Verlag 1981 Diabetologia (1981) 20:457-461 Diabetologia 9 Springer-Verlag 1981 A Prospective Study of Glomerular Filtration Rate and Arterial Blood Pressure in Insulin-Dependent Diabetics with Diabetic Nephropathy

More information

Hyperglycemia: Type I Diabetes Mellitus

Hyperglycemia: Type I Diabetes Mellitus 296 PHYSIOLOGY CASES AND PROBLEMS Case 53 Hyperglycemia: Type I Diabetes Mellitus David Mandel was diagnosed with type I (insulin-dependent) diabetes mellitus when he was 12 years old (see Cases 30 and

More information

Invited Revie W. Diabetic nephropathy: the modulating influence of glucose on transforming factor D production

Invited Revie W. Diabetic nephropathy: the modulating influence of glucose on transforming factor D production Histol Histopathol (1 998) 13: 565-574 Histology and Histopathology Invited Revie W Diabetic nephropathy: the modulating influence of glucose on transforming factor D production A.O. Phillips lnstitute

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Objectives: Know what Diabetic Nephropathy means. Know how common is Diabetic nephropathy in Saudi Arabia and to appreciate how bad are this complications. Know the risk factors of

More information

Diabetes has become the most common

Diabetes has become the most common P O S I T I O N S T A T E M E N T Diabetic Nephropathy AMERICAN DIABETES ASSOCIATION Diabetes has become the most common single cause of end-stage renal disease (ESRD) in the U.S. and Europe; this is due

More information

Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise

Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise Kidney International, Vol. 25 (1984), pp. 819 823 Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise CRAMER K. CHRISTENSEN Second University Clinic of Internal

More information

journal of medicine The new england Regression of Microalbuminuria in Type 1 Diabetes abstract

journal of medicine The new england Regression of Microalbuminuria in Type 1 Diabetes abstract The new england journal of medicine established in 1812 june 5, 2003 vol. 348 no. 23 Regression of Microalbuminuria in Type 1 Diabetes Bruce A. Perkins, M.D., M.P.H., Linda H. Ficociello, M.Sc., Kristen

More information

Introduction to Clinical Diagnosis Nephrology

Introduction to Clinical Diagnosis Nephrology Introduction to Clinical Diagnosis Nephrology I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University of Florida College

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Larry Lehrner, Ph.D.,M.D. llehrner@ksosn.com Commercial Support Acknowledgement: There is no outside support for this activity Financial Disclosure: stocks > 50,000 Bayer, J&J, Norvartis,Novo

More information

Renal function in diabetes mellitus

Renal function in diabetes mellitus Archives of Disease in Childhood, 1985, 60, 299-304 Original articles Renal function in diabetes mellitus A G DAVIES, D A PRICE, R J POSTLETHWAITE, G M ADDISON, J L BURN, AND B A FIELDING Royal Manchester

More information

Renal Protection Staying on Target

Renal Protection Staying on Target Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary

More information

Diabetes has become the most common

Diabetes has become the most common P O S I T I O N S T A T E M E N T Diabetic Nephropathy AMERICAN DIABETES ASSOCIATION Diabetes has become the most common single cause of end-stage renal disease (ESRD) in the U.S. and Europe; this is due

More information

Microvascular Disease in Type 1 Diabetes

Microvascular Disease in Type 1 Diabetes Microvascular Disease in Type 1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine The Course

More information

Laboratory Bulletin...

Laboratory Bulletin... Laboratory Bulletin... Updates and Information from Rex Healthcare and Rex Outreach February 1997 Issue Number 17 Urinary Microalbumin (an ideal test for real managed care) Microalbuminuria is the term

More information

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA Management of New-Onset Proteinuria in the Ambulatory Care Setting Akinlolu Ojo, MD, PhD, MBA Urine dipstick results Negative Trace between 15 and 30 mg/dl 1+ between 30 and 100 mg/dl 2+ between 100 and

More information

Pancreas Transplantation for the Prevention of Diabetic Nephropathy

Pancreas Transplantation for the Prevention of Diabetic Nephropathy Pancreas Transplantation for the Prevention of Diabetic Nephropathy MARK D. STEGALL, MD; TIMOTHY S. LARSON, MD; YOGISH SCOTT L. NYBERG, MD, PHD; MIKEL PRIETO, MD; JORGE Diabetic nephropathy is the leading

More information

Clinical Presentation from the Mario Negri Institute, Bergamo

Clinical Presentation from the Mario Negri Institute, Bergamo Nephrol Dial Transplant (90) 5:623-627 90 European Dialysis and Transplant Association-European Renal Association Nephrology Dialysis Transplantation Clinical Presentation from the Mario Negri Institute,

More information

protein: Creatininee ratio and HBA1c in type 2 diabetes with and without nephropathy diabetics without nephropathy

protein: Creatininee ratio and HBA1c in type 2 diabetes with and without nephropathy diabetics without nephropathy Original Research Article Correlation of 24-hour urinary protein, urinary protein: Creatininee ratio and HBA1c in type 2 diabetes with and without nephropathy S Mohammed 1, S Anees 2*, F Nazki 3 1,3 Resident

More information

Microalbumin ELISA. For the quantitative determination of albumin in human urine. For In Vitro Diagnostic Use.

Microalbumin ELISA. For the quantitative determination of albumin in human urine. For In Vitro Diagnostic Use. Microalbumin ELISA For the quantitative determination of albumin in human urine. For In Vitro Diagnostic Use. Catalog Number: Size: 24-MABHU-E01 96 Wells Version: ALPCO January 17, 2018 Page 1 of 9 I.

More information

Effect of Duration of Type I Diabetes on the Prevalence of Stages of Diabetic Nephropathy Defined by Urinary Albumin/Creatinine Ratio1

Effect of Duration of Type I Diabetes on the Prevalence of Stages of Diabetic Nephropathy Defined by Urinary Albumin/Creatinine Ratio1 Effect of Duration of Type I Diabetes on the Prevalence of Stages of Diabetic Nephropathy Defined by Urinary Albumin/Creatinine Ratio1 James H. Warram,2 Gary Gearin, Lori Laffel, and Andrzej S. Krolewski

More information

Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure

Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure 453 Original Article Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure Satoru MURAYAMA, Tsutomu HIRANO, Taro SAKAUE, Kenta OKADA,

More information

Evaluation of tests for microalbuminuria screening in patients with diabetes

Evaluation of tests for microalbuminuria screening in patients with diabetes Nephrol Dial Transplant (2005) 20: 2402 2407 doi:10.1093/ndt/gfi074 Advance Access publication 16 August 2005 Original Article Evaluation of tests for microalbuminuria screening in patients with diabetes

More information

The Utility of Conventional Dipsticks for Urinary Protein for Screening of Microalbuminuria in Diabetic Patients

The Utility of Conventional Dipsticks for Urinary Protein for Screening of Microalbuminuria in Diabetic Patients The Utility of Conventional Dipsticks for Urinary Protein for Screening of Microalbuminuria in Diabetic Patients SUPAMAI SOONTHORNPUN, M.D.*, ATCHARA THAMPRASIT, B.N.*, RATTAN A LEE LA WATT ANA, M.D.*,

More information

Functional and Morphological Renal Manifestations in Diabetes Mellitus

Functional and Morphological Renal Manifestations in Diabetes Mellitus Diabetologia (1981) 21:89-93 Diabetologia 9 Springer-Verlag 1981 Review Articles Functional and Morphological Renal Manifestations in Diabetes Mellitus C. E. Mogensen, M. W. Steffes, T. Deckert and J.

More information

Diabetic Nephropathy. Objectives:

Diabetic Nephropathy. Objectives: There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:

More information

Evaluation. Abstract: Introduction: Micro-vascular. ESRD. Due ARTICLE 1,2. treatment for DM Bhubaneswar life span resulting 3 Tutor.

Evaluation. Abstract: Introduction: Micro-vascular. ESRD. Due ARTICLE 1,2. treatment for DM Bhubaneswar life span resulting 3 Tutor. ORIGINAL RESEARCH ARTICLE http: ://www.eternalpublication.com INTERNATIONAL JOURNAL OF ANATOMY PHYSIOLOGY AND BIOCHEMISTRY IJAPB: Volume: 2; Issue: 6; June 2015 ISSN(Online):2394-3440 Evaluation of Biochemical

More information

Diabetes Care 23: , 2000

Diabetes Care 23: , 2000 Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Long-Term Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Patients With Diabetic Nephropathy LISE TARNOW, MD PETER

More information

Diabetologia 9 Springer-Verlag 1985

Diabetologia 9 Springer-Verlag 1985 Diabetologia (1985) 28:590-596 Diabetologia 9 Springer-Verlag 1985 The effect of proteinuria on relative mortality in Type (insulin-dependent) diabetes mellitus K. Borch-Johnsen 1, P. K. Andersen 2 and

More information

EFFECT OF BIOCHEMICAL PARAMETERS SHOWING ATHEROGENICITY IN TYPE 2 DIABETIC NEPHROPATHY

EFFECT OF BIOCHEMICAL PARAMETERS SHOWING ATHEROGENICITY IN TYPE 2 DIABETIC NEPHROPATHY EFFECT OF BIOCHEMICAL PARAMETERS SHOWING ATHEROGENICITY IN TYPE 2 DIABETIC NEPHROPATHY *G. Raja and Ivvala Anand Shaker * Department of Biochemistry, Melmaruvathur Adhiparasakthi Institute of Medical Sciences

More information

CORRELATION BETWEEN SERUM LIPID PROFILE AND ALBUMINURIA IN NORMOTENSIVE DIABETIC SUBJECTS Dr.Abhijit Basu 1*, Dr J.S. Jhala 2

CORRELATION BETWEEN SERUM LIPID PROFILE AND ALBUMINURIA IN NORMOTENSIVE DIABETIC SUBJECTS Dr.Abhijit Basu 1*, Dr J.S. Jhala 2 Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 CORRELATION BETWEEN SERUM LIPID PROFILE AND ALBUMINURIA IN NORMOTENSIVE DIABETIC SUBJECTS

More information

Acute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes

Acute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Acute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes JAMES T. LANE, MD 1 TIMOTHY

More information

Editorial for the month of November Homoeopathy in Diabetic Nephropathy

Editorial for the month of November Homoeopathy in Diabetic Nephropathy Editorial for the month of November 2009 Homoeopathy in Diabetic Nephropathy Diabetic nephropathy (nephropatia diabetica), also known as Kimmelstiel-Wilson syndrome and intercapillary glomerulonephritis,

More information

PAEDIATRIC MANAGEMENT KDIGO. Uma Ramaswami FRCPCH, MD Royal Free London NHS Foundation Trust

PAEDIATRIC MANAGEMENT KDIGO. Uma Ramaswami FRCPCH, MD Royal Free London NHS Foundation Trust PAEDIATRIC MANAGEMENT Uma Ramaswami FRCPCH, MD Royal Free London NHS Foundation Trust Disclosure of Interests UR has received travel grants and lecture fees from Shire HGT, Amicus and Genzyme; and advisory

More information

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation

More information

The hypertensive kidney and its Management

The hypertensive kidney and its Management The hypertensive kidney and its Management Dr H0 Chung Ping Hypertension Management Seminar 20061124 Hypertensive kidney Kidney damage asymptomatic till late stage Viscous cycle to augment renal damage

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Outline Introduction of diabetic nephropathy Manifestations of diabetic nephropathy Staging of diabetic nephropathy Microalbuminuria Diagnosis of diabetic nephropathy Treatment of

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy

The CARI Guidelines Caring for Australians with Renal Impairment. Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. All hypercholesterolaemic diabetics

More information

EARLY DIABETIC NEPHROPATHY. Roger K Ferguson, FACP, FACC, FCCP*

EARLY DIABETIC NEPHROPATHY. Roger K Ferguson, FACP, FACC, FCCP* Bahrain Medical Bulletin, Volume 18, Number 2, June 1996 Editorial EARLY DIABETIC NEPHROPATHY Roger K Ferguson, FACP, FACC, FCCP* Diabetes mellitus is becoming commoner in almost all parts of the world.

More information

It is well recognized that persons with non. Microalbuminuria, Blood Pressure, Metabolic Control, and Renal Involvement

It is well recognized that persons with non. Microalbuminuria, Blood Pressure, Metabolic Control, and Renal Involvement AJH 1997;10:189S 197S Microalbuminuria, Blood Pressure, Metabolic Control, and Renal Involvement Longitudinal Studies in White Non Insulin-Dependent Diabetic Patients Anita Schmitz In the present paper,

More information

Diabetologia 9 Springer-Verlag 1981

Diabetologia 9 Springer-Verlag 1981 Diabetologia (1981) 21 : 368-373 Diabetologia 9 Springer-Verlag 1981 Effect of Intravenous Glucose Infusion on Renal Function in Normal Man and in Insulin-Dependent Diabetics J. Sandahl Christiansen, M.

More information

Impaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus

Impaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus Original Research Article Impaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus Devabhaktuni Siva Sankar 1, Shaik Khaja Rassul 1* 1 Assistant Professor of Medicine,

More information

Glomerular size- and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

Glomerular size- and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy Diabetologia (1994) 37:195-21 Springer-Verlag 1994 Glomerular size- and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy M.-A. Gall, P. Rossing, A. Kofoed-Enevoldsen,

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

Chapter 23. Composition and Properties of Urine

Chapter 23. Composition and Properties of Urine Chapter 23 Composition and Properties of Urine Composition and Properties of Urine (1 of 2) urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless

More information

The increasing prevalence of obesity in children

The increasing prevalence of obesity in children IN THE LITERATURE Kidney Disease in Childhood-Onset Diabetes Commentary on Amin R, Widmer B, Prevost AT, et al: Risk of Microalbuminuria and Progression to Macroalbuminuria in a Cohort With Childhood Onset

More information

Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria

Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria Diabetologia (1996) 39: 1611 1616 Springer-Verlag 1996 Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria Ch. Schnack, W. Hoffmann, P. Hopmeier,

More information

Microalbuminuria in type 2 diabetic patients: a cross-sectional study of frequency, sex distribution and relation to hypertension

Microalbuminuria in type 2 diabetic patients: a cross-sectional study of frequency, sex distribution and relation to hypertension Original Article Ann Clin Biochem 1994; 31: 160-164 Microalbuminuria in type 2 diabetic patients: a cross-sectional study of frequency, sex distribution and relation to hypertension Thorkild Friis, Laurids

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

Neonatal renal function assessment

Neonatal renal function assessment Archives of Disease in Childhood, 1989, 64, 1264-1269 Neonatal renal function assessment P M R CLARK,* T N BRYANT,t M A HALL,* J A LOWES,t AND D J F ROWE *Special Care Baby Unit, Princess Anne Hospital,

More information

Obese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats

Obese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats Obese Type 2 Diabetic Model rats Rat Model with Early Onset of Diabetic Complications rats Background and Origin In 24, Dr. Masuyama and Dr. Shinohara (Research Laboratories of Torii Pharmaceutical Co.,

More information

THE KIDNEY IN DIABETES MELLITUS URINARY TRANSFERRIN EXCRETION, HYPERTENSION, AND THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THERAPY

THE KIDNEY IN DIABETES MELLITUS URINARY TRANSFERRIN EXCRETION, HYPERTENSION, AND THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THERAPY THE KIDNEY IN DIABETES MELLITUS URINARY TRANSFERRIN EXCRETION, HYPERTENSION, THE SYSTEM, AND THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THERAPY by MARK JOHN O'DONNELL A thesis submitted to

More information

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

More information

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment*

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment* Diabetologia (1998) 41: 745±759 Ó Springer-Verlag 1998 Review Renoprotection in diabetes: genetic and non-genetic risk factors and treatment* H.-H. Parving Steno Diabetes Center, Gentofte, Denmark Keywords

More information

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy http://www.kidney-international.org & 2011 International Society of Nephrology original article see commentary on page 1042 Tubular markers do not predict the decline in glomerular filtration rate in type

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

CLINICIAN INTERVIEW A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY. Interview with Ralph Rabkin, MD

CLINICIAN INTERVIEW A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY. Interview with Ralph Rabkin, MD A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY Interview with Ralph Rabkin, MD Dr Rabkin is Professor of Medicine, Emeritus, Active, at Stanford University School of Medicine, Stanford,

More information

Objectives. Kidney Complications With Diabetes. Case 10/21/2015

Objectives. Kidney Complications With Diabetes. Case 10/21/2015 Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

OST Course Schedule

OST Course Schedule OST 572 2017 Course Schedule Updated 03/06/2017 (aes) Week 1 Monday March 13, 2017 7:30-7:45 Course Syllabus /Schedule and announcements (posted on D2L) Kaufman Self Study Tuesday, March 14, 2017 1 Course

More information

Pregnancy and progression of diabetic nephropathy

Pregnancy and progression of diabetic nephropathy Diabetologia 2002) 45: 36±41 Ó Springer-Verlag 2002 Articles Pregnancy and progression of diabetic nephropathy K. Rossing, P. Jacobsen, E. Hommel, E. Mathiesen, A. Svenningsen, P. Rossing, H-H. Parving

More information

ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence?

ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence? Reviews ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence? George L. Bakris, MD; 1 and Matthew Weir, MD 2 Although angiotensin-converting

More information

www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to

More information

E.Ritz Heidelberg (Germany)

E.Ritz Heidelberg (Germany) Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Antihypertensive therapy in diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Antihypertensive therapy in diabetic nephropathy GUIDELINES Antihypertensive therapy in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Adequate control of blood pressure (BP) slows progression

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel

More information

Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM)

Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM) Postgrad Med J (1993) 69, 204-210 The Fellowship of Postgraduate Medicine, 1993 Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM) J.C.N.

More information

Diabetic Nephropathy. Introduction/Clinical Setting. Pathologic Findings Light Microscopy. J. Charles Jennette

Diabetic Nephropathy. Introduction/Clinical Setting. Pathologic Findings Light Microscopy. J. Charles Jennette 12 Diabetic Nephropathy J. Charles Jennette Introduction/Clinical Setting Diabetic nephropathy is a clinical syndrome in a patient with diabetes mellitus that is characterized by persistent albuminuria,

More information

ORIGINAL ARTICLE Urinary type IV collagen levels in diabetes mellitus

ORIGINAL ARTICLE Urinary type IV collagen levels in diabetes mellitus Malaysian J Pathol 21; 32(1) : 43 47 ORIGINAL ARTICLE Urinary type IV collagen levels in diabetes mellitus Pavai STHANESHWAR MBBS, MD and *Siew-Pheng CHAN MBBS, FRCP Departments of Pathology and *Medicine,

More information

REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY

REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY JCD REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY SAPTARSHI MUKHOPADHYAY* *FACULTY (DEPARTMENT OF MEDICINE), B R SINGH HOSPITAL (EASTERN RAILWAY), KOLKATA. INTRODUCTION renal disease. It

More information

Quantitative protein estimation of Urine

Quantitative protein estimation of Urine Quantitative protein estimation of Urine 1 In a healthy renal and urinary tract system, the urine contains no protein or only trace amounts. The presence of increased amounts of protein in the urine can

More information

Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes

Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes Kidney International, VoL 47 (1995), pp. 231 235 Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes ANDREA MANTO, PATRIZIA COTRONEO, GIAMPIERO Miu&, PAOLO MAGNANI, PIETRO

More information

Proteomics of renal disorders: Urinary proteome analysis by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry

Proteomics of renal disorders: Urinary proteome analysis by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry Proteomics of renal disorders: Urinary proteome analysis by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry Yadunanda Kumar*, Nageshwar Rao Venkata Uppuluri*, Kishore Babu #, Kishore

More information